In Brief: LifeScan/Novo Nordisk
This article was originally published in The Gray Sheet
Executive Summary
LifeScan/Novo Nordisk: Firms enter exclusive worldwide agreement "to bring two complementary product lines to people with diabetes -- Novo Nordisk's insulin products and future oral hypoglycemic agents, and LifeScan's blood glucose monitoring systems." Details will be announced in the future on how the agreement will be implemented on a country-by-country basis...